Want to see IN:MEDPLUS full AI Analyst Report?
MEDPLUS Stock Chart & Stats
₹808.80
₹1.40(0.17%)
At close: 4:00 PM EST
₹808.80
₹1.40(0.17%)
Day’s Range― - ―
52-Week Range₹647.25 - ₹1,020.35
Previous CloseN/A
Volume104.47K
Average Volume (3M)39.52K
Market Cap
₹82.70B
Enterprise Value₹108.84K
Total Cash (Recent Filing)₹6.13B
Total Debt (Recent Filing)₹0.00
Price to Earnings (P/E)38.6
Beta0.52
Next Earnings
Nov 05, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)17.55
Shares Outstanding120,137,060
10 Day Avg. Volume11,750
30 Day Avg. Volume39,524
Financial Highlights & Ratios
PEG Ratio0.99
Price to Book (P/B)5.10
Price to Sales (P/S)1.46
P/FCF Ratio24.91
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)18.13
Revenue Forecast (FY)₹80.52B
Bulls Say, Bears Say
Bulls Say
Consistent Revenue ExpansionSustained revenue expansion indicates growing customer reach and transaction volumes across MedPlus’s pharmacy network and omnichannel channels, supporting continued scale benefits and a durable base for future operating improvement.
Improved Free Cash FlowThe recent recovery in operating and free cash flow strengthens the company’s ability to fund store growth, digital fulfillment, inventory needs, and other investments internally, reducing reliance on external financing.
Growing Equity BaseSteady equity and asset growth provides financial support for the expanding retail platform. Although leverage is rising, the balance sheet remains reasonably supported, preserving capacity to invest in the business over the medium term.
Bears Say
Thin And Volatile MarginsLow profitability leaves limited protection against procurement costs, pricing pressure, and changes in product mix. The sharp 2026 gross-margin decline also raises concern that revenue growth may not translate proportionally into earnings.
Rising LeverageIncreasing leverage can constrain financial flexibility for a thin-margin retailer, particularly if working-capital needs or expansion spending rise. Higher debt reliance may also amplify pressure on earnings and cash flow during weaker operating periods.
Inconsistent Cash ConversionUneven conversion of accounting profit into cash suggests working-capital requirements or reinvestment demands remain material. This may limit the cash available for expansion, debt reduction, and shareholder returns even when reported earnings grow.
MedPlus Health Services Ltd. News
MEDPLUS FAQ
What was MedPlus Health Services Ltd.’s price range in the past 12 months?
MedPlus Health Services Ltd. lowest stock price was ₹647.25 and its highest was ₹1020.35 in the past 12 months.
What is MedPlus Health Services Ltd.’s market cap?
MedPlus Health Services Ltd.’s market cap is ₹82.70B.
When is MedPlus Health Services Ltd.’s upcoming earnings report date?
MedPlus Health Services Ltd.’s upcoming earnings report date is Nov 05, 2026 which is in 71 days.
How were MedPlus Health Services Ltd.’s earnings last quarter?
MedPlus Health Services Ltd. released its earnings results on Jul 21, 2026. The company reported ₹2.8 earnings per share for the quarter, beating the consensus estimate of ₹1.95 by ₹0.85.
Is MedPlus Health Services Ltd. overvalued?
According to Wall Street analysts MedPlus Health Services Ltd.’s price is currently Overvalued.
Does MedPlus Health Services Ltd. pay dividends?
MedPlus Health Services Ltd. does not currently pay dividends.
What is MedPlus Health Services Ltd.’s EPS estimate?
MedPlus Health Services Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does MedPlus Health Services Ltd. have?
MedPlus Health Services Ltd. has 120,137,060 shares outstanding.
What happened to MedPlus Health Services Ltd.’s price movement after its last earnings report?
MedPlus Health Services Ltd. reported an EPS of ₹2.8 in its last earnings report, beating expectations of ₹1.95. Following the earnings report the stock price went down -0.693%.
Which hedge fund is a major shareholder of MedPlus Health Services Ltd.?
Currently, no hedge funds are holding shares in IN:MEDPLUS
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
MedPlus Health Services Ltd.
MedPlus Health Services Limited operates primarily as an Indian retailer of pharmaceutical products and diverse general merchandise. Its extensive product catalog includes vital health and wellness items such as prescription medications, vitamins, medical equipment, and diagnostic kits, alongside everyday essentials like toiletries, baby care products, cleaning supplies, and sanitizers. Beyond its retail footprint, the company also offers wholesale cash-and-carry services, comprehensive pathological laboratory testing, and contract manufacturing for its own-brand pharmaceutical goods. By March 31, 2021, MedPlus had established a substantial presence with 1,659 brick-and-mortar stores situated in the Indian states of Karnataka, Tamil Nadu, Telangana, and Andhra Pradesh, complemented by its online store. This Hyderabad-based company was incorporated in 2006.
Technical Analysis
Krsnaa Diagnostics Limited
―
Dr. Lal PathLabs Limited
―
Metropolis Healthcare Ltd.
―
Sastasundar Ventures Limited
―
Thyrocare Technologies Ltd
―